XKON/270210 (XKON/270210)

Korea New Exchange: XKON/270210 · KRW

₩9,600

+390.00 (+4.2%)· Recorded snapshot

Market cap	16.3B
Revenue (ttm)	1.6B
Net income (ttm)	-77M
EPS (ttm)	-₩1,924
Shares out	1.7M
Volume	1
Beta	0.57

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.6B
Net income (ttm): -77M
EPS (ttm): -₩1,924
Market cap: 16.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-13.2

P25 n/aP50 n/aP75 n/a

ROIC2.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All XKON/270210 indicators

Market & fundamental data

Available fields

155

Groups with data

Currency

KRW

Showing 155 of 155 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Fiscal year end	December
Founded	2005
Industry	Perfumes, Cosmetics, and Other Toilet Preparations
Is primary listing	Yes
ISIN number	KR7270210008
Last refreshed	2026-10-28
Market cap	KRW 16.3B
Price	KRW 9,600.00
Price currency	KRW
SIC code	2844
Stock price date	2026-10-27
Symbol	xkon/270210
Website	https://srbiotek.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-20.04%
FCF yield	0.14%
Industry P/E	29.04x
P/B ratio	29.95x
P/FCF ratio	726.64x
P/OCF ratio	103.8x
P/S ratio	10.06x
Price / tangible book value	29.99x
Price/EBITDA ratio	54.15x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	3.18%
EBITDA margin	18.57%
FCF margin	1.38%
Gross margin	45.96%
Operating margin	3.18%
Pretax margin	-4.6%
Profit margin	-4.75%
ROA	1.2%
ROCE	3.06%
ROE	-13.21%
ROIC	2.65%
Tax / revenue	0.15%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue growth	-13.67%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -134.6M
Depreciation and amortization	KRW 249.4M
EBIT	KRW 51.5M
EBITDA	KRW 300.9M
EPS	KRW -1,924.04
FCF per share	KRW 13.47
Financing cash flow	KRW -120.3M
Free cash flow	KRW 22.4M
Gross profit	KRW 744.6M
Income taxes	KRW 2.4M
Investing cash flow	KRW -241.5M
Net borrowing	KRW -120.3M
Net cash flow	KRW -204.8M
Net income	KRW -77M
Operating income	KRW 51.5M
Revenue	KRW 1.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.8
Book value per share	KRW 13,599.45
Debt / EBITDA	5.69
Debt / equity	3.15
Debt / FCF	76.38
Interest coverage	1.01
Long-term assets	KRW 1.9B
Long-term liabilities	KRW 1.1B
Net cash (debt)	KRW -1.4B
Net cash / market cap	-8.31%
Net debt / EBITDA	4.5
Net debt / equity	2.49
Net debt / FCF	60.36
Piotroski F-Score	3
Property, plant and equipment	KRW 1.9B
Shareholders' equity	KRW 544.1M
Tangible book value	KRW 543.4M
Tangible book value per share	KRW 13,583.15
Total assets	KRW 2.5B
Total cash	KRW 359.1M
Total debt	KRW 1.7B
Total liabilities	KRW 2B
WACC	6.89%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.61
Current assets	KRW 674.6M
Current liabilities	KRW 863.1M
Current ratio	0.78
Inventory turnover	2.98
Net working capital	KRW 231.3M
Quick ratio	0.45
Working capital	KRW -188.6M

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	KRW 14,863.47
1D price change	4.23%
1M price change	-23.14%
1M total return	-23.14%
1W price change	-2.04%
1W total return	-2.04%
1Y price change	-37.58%
1Y return CAGR	-37.6%
1Y total return	-37.58%
20-day SMA	KRW 10,843.50
200-day SMA	KRW 17,282.95
3M price change	-28.84%
3M total return	-28.84%
3Y price change	131.33%
3Y return CAGR	32.25%
3Y total return	131.33%
50-day SMA	KRW 11,645.00
50-day SMA vs 200-day SMA	50under200
52-week high	KRW 33,950.00
52-week high date	2026-03-03
52-week low	KRW 8,010.00
52-week low date	2026-06-26
5Y price change	101.68%
5Y return CAGR	18.24%
5Y total return	131.07%
6M price change	-49.37%
6M total return	-49.37%
All-time high	KRW 46,000.00
All-time high date	2025-01-07
All-time low	KRW 2,510.00
All-time low date	2022-09-29
Average true range (ATR)	KRW 687.33
Average volume	299.6
Beta (1Y)	-0.09
Beta (2Y)	-0.32
Beta (5Y)	0.57
Change from 52-week high	-71.72%
Change from 52-week low	19.85%
Change from all-time high	-79.13%
Change from all-time low	282.47%
Change from open	0%
Day's gap	4.23%
Dollar volume	KRW 9,600
High price	KRW 9,600.00
Low price	KRW 9,600.00
Monthly RSI	43.08
Open price	KRW 9,600.00
Previous close	KRW 9,210.00
Price vs 150-day SMA	-35.41%
Price vs 20-day SMA	-11.47%
Price vs 200-day SMA	-44.45%
Price vs 50-day SMA	-17.56%
Relative volume	0
RSI	32.54
Sharpe ratio	-0.39
Sharpe ratio (3Y)	0.65
Sharpe ratio (5Y)	0.63
Sortino ratio	-0.5
Sortino ratio (3Y)	1.03
Sortino ratio (5Y)	0.98
Volume	1
Weekly RSI	36.35
YTD price change	-55.66%
YTD total return	-55.66%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.7M
Shares held by insiders	0.48%
Shares outstanding	1.7M

Deeper analysis on XKON/270210

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this XKON/270210 report

Is a complete XKON/270210 research report available?

No complete published report is available for xkon/270210 (XKON/270210) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

XKON/270210 (XKON/270210)

Price

Financial snapshot

Fair-value bridge

Latest news · XKON/270210

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XKON/270210 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on XKON/270210

Frequently asked questions